Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptomatic Non-erosive Gastroesophageal Reflux Disease”

11 trials

Showing 11 of 11 results

Not applicableLooking for participantsNCT06660342
What this trial is testing

The Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring

Who this might be right for
Erosive EsophagitisHeartburnSymptomatic Non-erosive Gastroesophageal Reflux Disease+1 more
Phathom Pharmaceuticals, Inc. 728
Large-scale testing (Phase 3)Study completedNCT00326027
What this trial is testing

Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004)

Who this might be right for
Gastroesophageal Reflux
Nycomed 29
Testing effectiveness (Phase 2)Study completedNCT00165841
What this trial is testing

Maintenance Intermittent Therapy for Symptomatic GERD Patients

Who this might be right for
Gastroesophageal Reflux Disease
Eisai Inc. 200
Not applicableStudy completedNCT00830115
What this trial is testing

Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders

Who this might be right for
Sleep DisordersNon-Erosive Reflux DiseaseGastroesophageal Reflux Disease
Nycomed 1,045
Testing effectiveness (Phase 2)Study completedNCT04799158
What this trial is testing

Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease

Who this might be right for
Non-Erosive Gastro-Esophageal Reflux DiseaseHeartburn
Phathom Pharmaceuticals, Inc. 458
Large-scale testing (Phase 3)Study completedNCT00163306
What this trial is testing

Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)

Who this might be right for
Gastroesophageal Reflux
Takeda 1,200
Large-scale testing (Phase 3)Study completedNCT05195528
What this trial is testing

Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)

Who this might be right for
Non-Erosive Gastro-Esophageal Reflux DiseaseHeartburn
Phathom Pharmaceuticals, Inc. 776
Large-scale testing (Phase 3)Study completedNCT00627016
What this trial is testing

Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

Who this might be right for
Gastroesophageal Reflux
Takeda 305
Large-scale testing (Phase 3)Study completedNCT00251758
What this trial is testing

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Who this might be right for
Gastroesophageal Reflux Disease
Takeda 908
Large-scale testing (Phase 3)Study completedNCT00251745
What this trial is testing

Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Who this might be right for
Gastroesophageal Reflux Disease
Takeda 908
Testing effectiveness (Phase 2)Study completedNCT01642602
What this trial is testing

Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents

Who this might be right for
Gastroesophageal Reflux Disease
Takeda 104

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation